Abca-1 elevating compounds

Details for Australian Patent Application No. 2002239508 (hide)

International Classifications

Event Publications

7 April 2005 Application Accepted

Published as AU-B-2002239508

4 August 2005 Standard Patent Sealed

1 September 2005 Corrigenda

Applications Accepted - Name Index Under the name CV Therapeutics, Inc., Application No. 2002239508, under INID (54) correct the title to read Substituted 1, 3, 5-triazines and pyrimidines as ABCA-1 elevating compounds against coronary artery disease or atherosclerosis.

12 November 2009 Amendment Made

The nature of the amendment is: Amend the patentee name from CV Therapeutics, Inc. to Gilead Palo Alto, Inc.

1 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.